Mar 03, 2021 / 03:20PM GMT
Stephen Michael Scala - Cowen and Company, LLC, Research Division - MD & Senior Research Analyst
Good morning, and welcome to the Bristol-Myers Squibb session within the Cowen 41st Annual Healthcare Conference. We're delighted have Bristol with us again this year.
Representing the company is Samit Hirawat, who's Executive Vice President and Chief Medical Officer. There's so many new developments and new products and new initiatives at Bristol that it's a full-time job to keep track of them all. But the best person on the planet to give us an update on all of them is Samit. So Samit, thank you so much for spending this time with us.
Samit Hirawat - Bristol-Myers Squibb Company - Executive VP & Chief Medical Officer of Global Drug Development
Thank you, Steve.
Questions and Answers:
Stephen Michael Scala - Cowen and Company, LLC, Research Division - MD & Senior Research AnalystI'd like to start out by asking, Bristol has numerous -- has had numerous positive clinical trial readouts over the